Physician profile
Stephanie Swanson
NPI 1811285612
$290.14
in general payments reported to CMS, 2019-2025
12 companies · $7.54 in 2025
The $7.54 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $13.64 · 2025: $7.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $76.96 | 2019 | |
| Vertical Pharmaceuticals, LLC | $35.38 | 2019 | |
| Avion Pharmaceuticals | $32.39 | 2019 | |
| Abbvie INC. | $30.92 | 2019 | |
| Duchesnay USA Incorporated | $23.96 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.94 | 2019 | |
| Allergan, INC. | $14.95 | 2019 | |
| Therapeuticsmd, INC. | $14.56 | 2019 | |
| Coopersurgical, INC. | $13.64 | 2020 | |
| Hologic Sales and Service, LLC | $12.92 | 2019 | |
| Mission Pharmacal Company | $10.98 | 2019 | |
| Organon LLC | $7.54 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.